24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Uveitis
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:23
El Al cancels Vietnam route after Shin Bet blocks security approval
21:15
Teva's Israeli identity becomes a courtroom issue in U.S. price-fixing trial
21:08
Arrow maker IAI's record $35 billion backlog comes with an increasingly urgent cash problem
20:49
OpenAI recruits Wiz's COO to lead its next phase of growth
More stories
Buzz
Most popular
Daily
Weekly
1
LinkedIn to shut down Israeli R&D operations and lay off nearly all employees
2
Israeli AI startup Decart nearing $6 billion sale, Musk’s SpaceX circling
3
Anthropic in talks to acquire Israeli AI startup Decart for $6 billion
4
Covenant takes its long-range missile from secrecy to a live-fire test in Morocco
5
Palo Alto’s CEO bought the dip. Five months later, his $10 million bet is worth $26 million
More news
Uveitis
1 stories about Uveitis
How one female CEO overcame adversity to find a cure for Uveitis
04.02.22
|
Roni Dori
"I see us building a large company that will focus on the eye, beyond Uveitis. Our technology has tremendous potential to treat other diseases that cause blindness, and treat millions of patients," says Dr. Daphne Haim-Langford, who suffers from Uveitis and founded Tarsier Pharma